Complete Information on Acidemia propionic with Treatment and Prevention

Acidemia propionic is an organic aciduria produced by the deficiency of propionyl CoA-carboxylase, producing a ketotic hyperglycinemia and recurrent metabolic imbalance. In this disorder the body is unable to process certain parts of proteins and lipids properly. The condition appears to be more common in several populations worldwide, including the Inuit population of Greenland, some Amish communities, and Saudi Arabians. Death can occur quickly, due to secondary hyperammonemia, infection, cardiomyopathy, or basal ganglial stroke. Acidemia propionic is characterized almost immediately in newborns. Symptoms include poor feeding, vomiting, dehydration, acidosis, low muscle tone, seizures, and lethargy. The effects of propionic acidemia quickly become life-threatening.

The signs and symptoms of acidemia propionic seem during childhood and may go and get over moment. Some stricken children see psychological retardation or delayed growth. Mutations in the PCCA and PCCB genes induce propionic acidemia. The PCCA and PCCB genes take protein subunits that go jointly to organize an enzyme called propionyl-CoA carboxylase. This enzyme is accountable for one measure in the dislocation of several amino acids, sure lipids, and cholesterol. Without proper handling, coma and possibly severe complications may ensue. In uncommon cases, the circumstance may get obvious subsequently during infancy and may be associated with little serious symptoms and findings.

Acidemia propionic most often follows an autosomal recessive inheritance pattern. People uses many new names for propionic acidemia, some are hyperglycinemia with ketoacidosis and leukopenia, ketotic glycinemia, ketotic hyperglycinemia, propionicacidemia etc. With recessive disorders affected patients usually have two copies of a disease gene in order to show symptoms. People with only one copy of the disease gene generally do not show signs or symptoms of the condition but can pass the disease gene to their children. Because the diagnosis and therapy of metabolic disorders like Acidemia propionic is complex, the pediatrician is advised to manage the patient in close collaboration with a consulting pediatric metabolic disease specialist.

The effects of Acidemia propionic can be life-threatening. Acidemia propionic patients need new treatments and the development of a viable gene therapy to address the heart of the problem: replace the patient's altered PCCA or PCCB genes with functional copies so the patient can produce enough Propionyl-CoA carboxylase to consume a normal diet. Treatment of Acidemia propionic involves reducing protein intake, particularly the amino acids Valine, Isoleucine, Methionine, and Threonine that feed into the defective pathway. This requires placing the infant on a special metabolic formula depleted in these amino acids. Until the diagnosis of acidemia propionic is clearly established, all patients should be given a trial of cobalamin and biotin to evaluate a response. Prevention of constipation is important. Strict control is most crucial throughout childhood. Rarely, older patients with mild forms of Acidemia propionic are reported to function untreated.